Arca
Skip to content
Tools
Tools

Human Igm Csf Kit

Method, Nephelometric, Immunoglobulins (G, A, M). 510(k) K120750, from The Binding Site Group , Ltd. (Birmingham, GB). Product code CFN, class 2.

As of Nov 18, 2026, K120750 is an FDA 510(k) held by The Binding Site Group , Ltd., substantially equivalent on May 17, 2013 after 431 days, with no recalls tied to it in FDA's recall database.

  • Review time: 431 days
  • Recalls: 0
  • Cited as a predicate by: 1 device

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

Human IgM CSF kit for use on SPAPPLUS is intended for the quantitative measurement of human IgM in cerebrospinal fluid (CSF) samples using the SPAPPLUS analyser. Measurement of this immunoglobulin aids in the assessment of the body's lack of ability to resist infectious disease in conjunction with other clinical and laboratory findings.

Cited as a predicate

1 later 510(k) summary names this device as a predicate

Other CFN clearances

The newest 510(k)s for the same product code; see every CFN device

Record

Type
Traditional
Received
Mar 12, 2012
Review panel
Immunology
Regulation
21 CFR 866.5510

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.